Summary

The pharmaceutical industry has been responsible for the successful execution of hundreds of thousands of trials of new drugs and vaccines. Gene therapy trials are unique, combining established experience and new approaches previously unnecessary for developing new drugs. This white paper examines some of the considerations required for gene therapy trials, particularly in pediatric patients.